FDA Evaluating Methods For Communicating Product Risks To Doctors
This article was originally published in The Gray Sheet
Executive Summary
FDA is developing a major survey to improve its understanding of how practitioners obtain information about the risks of medical products
You may also be interested in...
Postmarket Transformation Plan Update With FDA’s Don St. Pierre
FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative
Postmarket Transformation Plan Update With FDA’s Don St. Pierre
FDA's device center set out on an ambitious path last year to revamp the way it oversees product safety in what it is calling its 1"postmarket transformation" initiative
FDA Will Look At Risk Communications In Two Separate Assessments
FDA plans to conduct multiple studies to assess how well it communicates information on medical risks to healthcare professionals